The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?
The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer's disease: agonists or antagonists?作者机构:Department of Biomedical Sciences and Biotechnologies Section of Human Anatomy and Histology University of Catania
出 版 物:《Neural Regeneration Research》 (中国神经再生研究(英文版))
年 卷 期:2015年第10卷第2期
页 面:205-207页
核心收录:
学科分类:1002[医学-临床医学] 100203[医学-老年医学] 10[医学]
主 题:The seeming paradox of adenosine receptors as targets for the treatment of Alzheimer’s disease agonists or antagonists
摘 要:Alzheimer's disease (AD) is the most common neurodegenerative disorder, and its incidence is relatively high among elderly people, affecting about 1-2% of the population between 60-65 years old and rising dramatically (about 30%) in people aged 80 years or older (Selkoe, 2002). Nowadays, considering the increasing mean lifespan of populations in developed countries, the disease is becoming more and more a health concern, and the search for an effective cure has turned into"a real need".